申请人:——
公开号:US20040110763A1
公开(公告)日:2004-06-10
A pyrazolopyridine compound of formula (I) wherein: R
1
is hydrogen, lower alkyl optionally substituted by susbtituent(s), or cyclo(lower)alkyl which may be interrupted by an oxygen or nitrogen atom and optionally substituted by substituent(s); R
2
is hydrogen, halogen or lower alkoxy; R
3
is a substituent; and n is an integer from 1 to 4, provided R
3
may be different from each other when n is 2, 3 or 4, or a salt thereof. The pyrazolopyridine compound (I) and salt thereof of the present invention are adnosine antagonists and are useful for the prevention and/or treatment of depression, dementia (e.g. Alzheimer's disease, cerebrovascular dementia, dementia accompanying Parkinson's disease, etc.) Parkinson's disease, anxiety, pain, cerebrovascular disease (e.g. stroke, etc.), heart failure and the like.
1
化合物(I)为吡唑吡啶化合物,其化学式为:其中,R1为氢、低碳基(可选择性地被取代)或环(低)烷基,其可由氧或氮原子中断,且可选择性地被取代;R2为氢、卤素或低烷氧基;R3为取代基;n为1至4的整数,但当n为2、3或4时,R3可能彼此不同,或其盐。本发明的吡唑吡啶化合物(I)及其盐为腺苷受体拮抗剂,可用于预防和/或治疗抑郁症、痴呆症(例如阿尔茨海默病、脑血管痴呆、帕金森病伴随痴呆等)、帕金森病、焦虑症、疼痛、脑血管疾病(例如中风等)、心力衰竭等疾病。